
Abstract 192: Preclinical evaluation of TQBWX220, a small-molecule inhibitor of IDO1
Author(s) -
Shilan Liu,
GuiBai Liang,
Dahai Wang,
Shuhui Chen,
Wenyuan Qian,
Chi-Chung Chan,
Xiquan Zhang,
Lin Yang,
Xin Tian,
Yong Gao,
Tiantian Dong,
Mei Liu,
Lihua He
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-192
Subject(s) - indoleamine 2,3 dioxygenase , chemistry , pi3k/akt/mtor pathway , potency , pharmacology , cancer research , tumor microenvironment , effector , cd8 , immune system , signal transduction , in vitro , biochemistry , biology , immunology , tryptophan , amino acid